Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Chabner

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
The Oncologist|January 28, 2017
Let This Be Our New Year's PledgeBruce A Chabner, Martin J Murphy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2022
Joseph R. Bertino, Scientist and Clinical OncologistBruce A Chabner, George P Canellos
The Oncologist|April 19, 2018
Canakinumab and Lung Cancer: Intriguing, but Is It Real?Bruce A Chabner, Christopher S Nabel
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 5, 2002
Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal womenArmen H Tashjian, Bruce A Chabner
Nature Reviews. Cancer|January 5, 2005
Timeline: Chemotherapy and the war on cancerBruce A Chabner, Thomas G Roberts
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Clarification regarding "phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties" and the accompanying commentary, "phase II cancer trials: out of control?"Bruce A Chabner, Mark J Ratain
The Oncologist|July 16, 2015
Ponatinib: Accelerated DisapprovalJustin F Gainor, Bruce A Chabner
The Oncologist|June 8, 2022
Supreme Court and the Practice of OncologyBruce A Chabner, Susan E Bates
The New England Journal of Medicine|January 31, 2019
Cell-free DNA Analysis in CancerRyan B Corcoran, Bruce A Chabner
The Oncologist|April 9, 2020
The Finding of N-Nitrosodimethylamine in Common MedicinesRichard H Adamson, Bruce A Chabner
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
The Oncologist|January 28, 2017
Let This Be Our New Year's PledgeBruce A Chabner, Martin J Murphy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2022
Joseph R. Bertino, Scientist and Clinical OncologistBruce A Chabner, George P Canellos
The Oncologist|April 19, 2018
Canakinumab and Lung Cancer: Intriguing, but Is It Real?Bruce A Chabner, Christopher S Nabel
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 5, 2002
Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal womenArmen H Tashjian, Bruce A Chabner
Nature Reviews. Cancer|January 5, 2005
Timeline: Chemotherapy and the war on cancerBruce A Chabner, Thomas G Roberts
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Clarification regarding "phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties" and the accompanying commentary, "phase II cancer trials: out of control?"Bruce A Chabner, Mark J Ratain
The Oncologist|July 16, 2015
Ponatinib: Accelerated DisapprovalJustin F Gainor, Bruce A Chabner
The Oncologist|June 8, 2022
Supreme Court and the Practice of OncologyBruce A Chabner, Susan E Bates
The New England Journal of Medicine|January 31, 2019
Cell-free DNA Analysis in CancerRyan B Corcoran, Bruce A Chabner
The Oncologist|April 9, 2020
The Finding of N-Nitrosodimethylamine in Common MedicinesRichard H Adamson, Bruce A Chabner
Pageof 14